Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04006535

Whole Exome Sequencing of Familial and Pediatric Forms of Vasculitis

The FAMILYVASC study is a prospective observational study which will aim to identify susceptibility loci and genes for systemic vasculitis risk in patients with familial or pediatric forms of vasculitis. Genetic analysis based on whole exome sequencing will be carried out through salivary DNA.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Cochin - Department of Internal Medicine

Paris, Île-de-France Region, 75014, France

Location status: Recruiting

Location contact

Benjamin Terrier, MD, PhD

CONTACT

[email protected]

+ 01 58 41 14 61

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for subjects with vasculitis

  • Children and adults
  • Patients with vasculitis, as defined in the Chapel Hill International Classification in its revised version of 2012
  • Patient information and signed informed consent
  • Pregnant and breastfeeding women can be included in the study

Inclusion criteria

for healthy subjects

  • Children and adults
  • Do not have vasculitis, as defined in the Chapel Hill International Classification in its revised version of 2012, or relatives on the 1st; 2nd; 3rd or 4th degree of a patient with vasculitis
  • Patient information and signed informed consent
  • Pregnant and breastfeeding women can be included in the study

Exclusion criteria

  • Refusal of consent or inability to obtain consent
  • Dementia or unauthorized patient, for psychiatric or intellectual failure reasons, to receive information about the protocol and to give informed consent.
  • Uncooperative patient, or any pathology that could make the patient potentially non-compliant to the study procedures, and patients interned for regulatory or legal reasons.

Treatment and study plan

Genetic analysis

Genetic

Saliva sample collection for genetic analysis

Primary outcomes

  1. Identification of susceptibility loci and genes

    Time frame: At the moment of enrollment

Study contacts

Contact information is provided by the study sponsor or research team.

Benjamin Terrier, MD, PhD

CONTACT

[email protected]

+33 1 58 41 14 61

Hicham Kardaoui, MSc

CONTACT

[email protected]

+33 1 58 41 16 46

Sponsors and collaborators

Lead sponsor

Benjamin Terrier

Other

Registry information

Official study title

Identification of Susceptibility Loci and Genes for Systemic Vasculitis Risk, by Analyzing Whole Exome Sequencing of Familial and Pediatric Forms of Vasculitis (FAMILYVASC Study)

Acronym: FAMILYVASC

Important dates

Study start
2019
Primary completion
2029
Study completion
2029
First posted
Jul 5, 2019
Registry last updated
Jul 8, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.